IL2 and melanoma: Recent reports also describe the successful combination of IL‐2 treatment with cell cycle checkpoint inhibitors, which was able to overcome previous resistance to these drugs in patients with advanced melanoma,108 paving the way for further studies on the adjuvant use of IL‐2 to improve responses to existing chemotherapeutic agents.